The impact of immunosenescence on the efficacy of immune checkpoint inhibitors in melanoma patients: a meta-analysis

BACKGROUND: Immunosenescence, the age-related decline of immunity, affects the immune responses of melanoma patients. Through immune responses, immune checkpoint inhibitors (ICIs) exert their antitumor robustness. In different ages of melanoma patients, especially the older patients, the effectivene...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ping, Yang, Xuefang, Feng, Yumiao, Wu, Lijuan, Ma, Wei, Ding, Gaozhong, Wei, Yun, Sun, Lan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208870/
https://www.ncbi.nlm.nih.gov/pubmed/30464500
http://dx.doi.org/10.2147/OTT.S165368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208870/
https://www.ncbi.nlm.nih.gov/pubmed/30464500
http://dx.doi.org/10.2147/OTT.S165368

Ejemplares similares